Prescient Therapeutics

Level 4, 100 Albert Road, SOUTH MELBOURNE, 3205
03 9692 7222

Article Timeline

Network Graph

Displaying all people that are connected to 2 or more organisations. Hover over a node to display a link to the BNiQ page for that person or organisation.

Notable People

Showing 5 people. Position shown in italic is their previous role in the same organisation.
 Most Senior WA Executive.

NamePositionYear Started
James Campbell
James Campbell
Non-Executive Director2014
Steven Engle
Steven Engle
Non-Executive Chairman2014
Paul Hopper
Paul Hopper
Non-Executive Director
Executive Director (2014 to 2017)
James Winkler
James Winkler
Vice President, Business Development2018
Steven Yatomi-Clarke
Steven Yatomi-Clarke
Chief Executive Officer, Managing Director2014

Past People

NamePositionYear StartedYear Ended
Paul Hopper Executive Director20142017
Sean Henbury Company Secretary20132015
Rob Crombie Managing Director20142015
Wayne Millen Non-Executive Chairman20132014
Brendan de Kauwe Non-Executive Director20132014
Roland Toder Non-Executive Director20132014

ECM Deals

DateCompanyTransaction TypeTotal Value
30/06/16Prescient TherapeuticsEntitlement offer$3.4m>>
18/05/16Prescient TherapeuticsPlacement$7.0m>>
23/11/15Prescient TherapeuticsEntitlement offer$1.0m>>
28/03/14Prescient TherapeuticsPlacement$3.0m>>

M&A Deals

AnnouncedBidderTargetTransaction TypeTotal Value
17/03/14Prescient TherapeuticsPathway OncologyReverse takeover$3.6m>>


Prescient Therapeutics, formerly known as Virax Holdings, is a clinical stage oncology company developing novel compounds that show great promise as potential new therapies to treat a range of cancers that have become resistant to front line chemotherapy.
Biography last updated 06 Mar 2019

Share Transactions

$4k Bought
$13k Issued
$0 Issued
Total value as at the date of the transaction
Source: Morningstar

BNiQ Disclaimer